Search PDMR transactions

Notifier
Name
Bent Frandsen
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Bent Frandsen
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name
ExpreS2ion Biotech Holding AB
LEI
549300FJK50P1ORYJC45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Warrant EXPRS2 TO4 SE0014958328 Issue of instrument 19,000 Quantity 0.00 SEK 16/11/2020 NASDAQ STOCKHOLM AB
Warrant EXPRS2 TO5 SE0014958336 Issue of instrument 19,000 Quantity 0.00 SEK 16/11/2020 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
EXPRS2 TO4 SE0014958328 Issue of instrument 16/11/2020 NASDAQ STOCKHOLM AB 19,000 (Quantity) 0.00 SEK
EXPRS2 TO5 SE0014958336 Issue of instrument 16/11/2020 NASDAQ STOCKHOLM AB 19,000 (Quantity) 0.00 SEK
<< Back